Craig R. Stapleton, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 140,000 shares at $8.67 ($1.2M) on 2017-12-15, disclosed to the SEC on 2017-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.67 | 70,000 | $607K | 50.0% |
| 2 | $8.67 | 70,000 | $607K | 50.0% |
| Total | $8.67 avg | 140,000 | $1.2M | 100% |
| Filing → |
| AVDL | BUY | 2017-05-22 | $305K | — | Filing → |
| FLML | BUY | 2016-11-30 | $216K | — | Filing → |
| ANF | BUY | 2016-09-06 | $177K | — | Filing → |